Zacks Investment Research Lowers CRH Medical (CRHM) to Sell

Share on StockTwits

Zacks Investment Research cut shares of CRH Medical (NYSEAMERICAN:CRHM) from a hold rating to a sell rating in a research report released on Tuesday morning.

According to Zacks, “CRH Medical Corporation offers products and services to physicians for the treatment of gastrointestinal diseases primarily in the United States. The company provides the CRH O’Regan System, a single use, disposable and hemorrhoid banding technology for treating hemorrhoid grades I – IV. It distributes the CRH O’Regan System, treatment protocols, operational and marketing expertise as a complete, turnkey package directly to physicians. The company utilizes Web-based platform to connect doctors with patients as well as educating its install base of physicians. It also offers anesthesia services. CRH Medical Corporation is headquartered in Vancouver, Canada. “

Other research analysts also recently issued reports about the company. TheStreet raised CRH Medical from a c rating to a b- rating in a report on Friday, August 24th. TD Securities raised CRH Medical from a hold rating to a buy rating in a report on Friday, July 27th.

NYSEAMERICAN CRHM opened at $3.25 on Tuesday. CRH Medical has a 1-year low of $1.46 and a 1-year high of $4.50.

A number of large investors have recently bought and sold shares of the business. ClariVest Asset Management LLC acquired a new position in CRH Medical during the 3rd quarter worth $154,000. JPMorgan Chase & Co. raised its position in shares of CRH Medical by 38.0% during the 3rd quarter. JPMorgan Chase & Co. now owns 1,486,400 shares of the company’s stock valued at $5,871,000 after acquiring an additional 409,100 shares during the last quarter. Wedge Capital Management L L P NC bought a new stake in shares of CRH Medical during the 3rd quarter valued at $373,000. Acadian Asset Management LLC bought a new stake in shares of CRH Medical during the 3rd quarter valued at $354,000. Finally, Nantahala Capital Management LLC raised its position in shares of CRH Medical by 25.5% during the 2nd quarter. Nantahala Capital Management LLC now owns 4,919,614 shares of the company’s stock valued at $15,396,000 after acquiring an additional 998,421 shares during the last quarter.

About CRH Medical

CRH Medical Corporation provides various products and services to gastroenterologists for the treatment of gastrointestinal diseases in the United States, Canada, and internationally. It offers CRH O'Regan system, a single use, disposable, and hemorrhoid banding technology for treating various grades of hemorrhoid.

Featured Article: How are the companies in the S&P 500 selected?

Get a free copy of the Zacks research report on CRH Medical (CRHM)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for CRH Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CRH Medical and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply